POLISCOPE
Back to feed
FEDERALhearing transcript
High Impact

Congressional Hearing on the 2019 Novel Coronavirus (February 5, 2020)

Original title: THE WUHAN CORONAVIRUS: ASSESSING THE OUTBREAK, THE RESPONSE, AND REGIONAL IMPLICATIONS

January 1, 2022

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

This hearing established the initial congressional oversight framework for the federal government's response to the COVID-19 pandemic, highlighting early coordination challenges between the legislative and executive branches.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

U.S. House Subcommittee on Asia, the Pacific and Nonproliferation

The subcommittee is responsible for conducting oversight of the federal response to the public health emergency.

Executive Branch Administration

The Administration is the subject of congressional oversight regarding its management of the coronavirus outbreak.

What changed

Last recorded activity January 1, 2022.

What's next

Next step not available in the current record.

Summary

This document is the transcript of the first U.S. House hearing regarding the 2019 novel coronavirus outbreak. The hearing focused on assessing the public health response and regional implications of the virus, featuring testimony from health policy experts.

Key Facts

  • The hearing took place on February 5, 2020, in the Rayburn House Office Building.
  • This was the first congressional hearing held regarding the 2019 novel coronavirus.
  • The Subcommittee on Asia, the Pacific and Nonproliferation requested Administration officials to testify, but they did not appear at this specific public hearing.
  • Administration officials held a separate, non-televised, unclassified briefing for members of Congress earlier on the same day.
  • The subcommittee requested that the Administration provide their opening statements from the private briefing for the public record.
  • Witnesses included experts from Johns Hopkins University, the Rand Corporation, and a former White House Ebola Response Coordinator.

Frequently Asked Questions

Why did the Administration not attend this public hearing?
Chairman Bera noted that while the Administration did not send representatives to this public hearing, they did conduct a separate, non-televised, briefing for members of Congress earlier that day.
What was the primary purpose of this hearing?
The hearing was convened to assess the outbreak of the 2019 novel coronavirus, evaluate the federal response, and discuss regional implications.

Why It Matters

This hearing established the initial congressional oversight framework for the federal government's response to the COVID-19 pandemic, highlighting early coordination challenges between the legislative and executive branches.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Show 3 more sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift100% confidence

Early Congressional Oversight

The document captures the very beginning of the legislative branch's attempt to exert oversight over the executive branch's pandemic response.

Connected Entities

personAlex AzarSecretary of Health and Human ServicesMap →
personRobert RedfieldDirector of the CDCMap →
personJennifer NuzzoWitness, Associate Professor and Senior Scholar at Johns Hopkins Center for HealMap →
personMick MulvaneyActing Chief of StaffMap →
personAmi BeraChairman of the Subcommittee on Asia, the Pacific and NonproliferationMap →
personAnthony FauciDirector of the National Institute of Allergy and Infectious DiseasesMap →
personJennifer BoueyWitness, Senior Policy Researcher at Rand CorporationMap →
personRon KlainWitness, Former White House Ebola Response CoordinatorMap →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance95
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment20
    Compellingness for a non-policy-wonk reader
  • Buzz10
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record